Breast MRI

Indications & Technique - MRI Magnet Magic

• Key Indications:
  • High-risk screening (e.g., BRCA, prior chest RT < 30 yrs)
  • Problem solving (mammography/US inconclusive)
  • Staging: newly diagnosed cancer (esp. ILC), axillary occult primary
  • Neoadjuvant Chemotherapy (NACT) response
  • Implant integrity evaluation
  • Differentiating post-op scar vs. recurrence
• Core Technique:
  • Magnet: ≥ 1.5T (ideally 3T)
  • Coil: Dedicated phased-array breast coil, patient prone
  • Key Sequences:
    • T1W (pre & post-contrast): anatomy, enhancement
    • T2W/STIR: cysts, edema, nodes
    • DWI with ADC maps: cellularity assessment
    • Dynamic Contrast-Enhanced (DCE-MRI):
      • Gadolinium-based contrast
      • Kinetic curves: Type I (benign), II (suspicious), III (malignant)
  • Subtraction images: vital for detecting enhancing lesions

⭐ MRI is the most sensitive imaging modality for detecting invasive breast cancer, particularly in dense breasts.

BI-RADS MRI Lexicon - Lesion Lingo

• Lesion Types:
  • Focus: <5mm punctate enhancing spot, too small to characterize.
  • Mass: 3D lesion. Key descriptors:
    • Shape: Oval, round, irregular.
    • Margin: Circumscribed, irregular, spiculated.
    • Internal Enhancement: Homogeneous, heterogeneous, rim, dark septations.
  • Non-Mass Enhancement (NME): Enhancement not a mass (e.g., ductal, segmental).
    • Distribution: Focal, linear, segmental, regional.
    • Internal Pattern: Homogeneous, heterogeneous, clumped, stippled.
• Kinetic Curves (Signal Intensity vs. Time):
  • Type I (Progressive): Continuous signal ↑ (often benign).
  • Type II (Plateau): Initial ↑, then flat (intermediate).
  • Type III (Washout): Initial ↑, then signal ↓ (often malignant).

⭐ Spiculated margins, rim enhancement in a mass, or Type III (washout) kinetics are highly suspicious for malignancy.

Benign vs. Malignant - MRI Clue Hunt

Key Differentiators: Morphology & Kinetics.

Kinetic Curves (BI-RADS):

• Type 1 (Persistent): Progressive uptake (usually benign).
• Type 2 (Plateau): Initial rise, then plateau (suspicious).
• Type 3 (Washout): Rapid uptake, then rapid ↓ (highly suspicious).

  ⭐ A Type 3 (washout) kinetic curve is most specific for malignancy.

Other Malignant Pointers:

• NME: Segmental, Linear, Ductal, Clumped (📌 SLDC: Some Lions Don't Care).
• Restricted diffusion (DWI).
• Peritumoral edema, skin/nipple changes.

Special Applications - MRI's Superpowers

• Implant Integrity Assessment:
  • Detects silicone implant rupture (intracapsular vs. extracapsular).
  • Key signs: linguine (intracapsular), keyhole, silicone granulomas (extracapsular).
  • Silicone-sensitive sequences (water suppression).
• Neoadjuvant Chemotherapy (NACT) Response:
  • Assesses residual tumor post-NACT.
  • Predicts pCR (pathologic complete response).
  • Guides surgery (BCS vs. mastectomy).
• Problem Solving & Occult Cancer:
  • Clarifies equivocal mammography/US, esp. dense breasts.
  • Detects occult primary with axillary mets (CUP - Cancer of Unknown Primary).
• Extent of Disease Evaluation:
  • Accurate for multifocal/multicentric disease.
  • Assesses chest wall invasion.

  ⭐ MRI can detect additional unsuspected cancer in the same or opposite breast in 15-20% of newly diagnosed breast cancer patients. oka

High‑Yield Points - ⚡ Biggest Takeaways

• Breast MRI excels in high-risk screening (BRCA), evaluating disease extent, and monitoring neoadjuvant therapy response.
• BI-RADS lexicon standardizes reporting for MRI findings.
• Kinetic curve analysis: Type 3 (washout) strongly suggests malignancy.
• Suspicious morphology: Spiculated margins for masses, segmental/linear NME, and rim enhancement.
• Optimal scan timing for premenopausal women: days 7-14 of menstrual cycle to reduce BPE.
• Gadolinium-based contrast agents (GBCAs) are essential for evaluation.